Bowel Cancer Subtypes (C18-C20): 2011

Slides:

Advertisements

Similar presentations

© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Cervical Cancer - UK December 2011 For more information.

Advertisements

© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Breast Cancer - UK December 2011 For more information.

CANCER INCIDENCE IN THE UK, 2010 AUGUST All Cancers Excluding Non-Melanoma Skin Cancer (C00-97 Excl. C44): 2010 Number of New Cases, Crude and European.

© Cancer Research UK 2011 Registered charity in England and Wales ( ) and Scotland (SC041666) Colorectal Cancer - UK December 2011 For more information.

Breast Cancer (C50): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Age-Standardised Ten-Year Net Survival for the Most Common Cancers in Females, England and Wales, Ten-year survival for is predicted.

Non-Hodgkin Lymphoma (C82-C85):

Mesothelioma (C45): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Eye Cancer (C69): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Uterine Cancer (C54-C55): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.

Age-Standardised One-Year Net Survival, England and Wales

Hodgkin Lymphoma Subtypes:

Bladder Cancer (C67): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-99, England & Wales 1-Year 5-Year 10-Year Survival (%) Survival.

Ovarian Cancer (C56 C57.0-C57.7):

Soft Tissue Sarcoma (All Subtypes Combined): 2010

Cancer of Unknown Primary (C77-C80): 2013

Head & Neck Cancer (C00-C14, C30-C32): 2014

Prostate Cancer (C61): 2014 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.

Liver Cancer (C22): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Kidney Cancer (C64-C66 C68): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-99, England & Wales 1-Year 5-Year 10-Year Survival (%)

Soft Tissue Sarcoma (All Subtypes Combined):

All Cancers Excluding Non-Melanoma Skin Cancer (C00-C97 Excl

Vulval Cancer (C51): European Age-Standardised Incidence Rates per 100,000 Population, Females, Great Britain Please include the citation provided.

All Cancers Excluding Non-Melanoma Skin Cancer (C00-97 Excl

Uterine Cancer (C54-C55): Average Number of New Cases Per Year and Age-Specific Incidence Rates per 100,000 Population, Females, UK Please include.

Brain Cancer (C71): One-, Five- and Ten-Year Net Survival (%), Adults Aged 15-99, England & Wales 1-Year 5-Year 10-Year Survival (%) Survival.

Kidney Cancer (C64-C66,C68): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England.

Stomach Cancer (C16): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Bone Sarcoma (C40-C41): Average Number of Deaths Per Year and Age-Specific Mortality Rates per Million Population, UK Please include the citation.

Testicular Cancer (C62): 2008 Estimates

All Childhood Cancers:

Uterine Cancer (C54-C55): European Age-Standardised Incidence Rates per 100,000 Population, Females, Great Britain Please include the citation.

Kidney Cancer (C64-C66,C68): Average Number of New Cases Per Year and Age-Specific Incidence Rates per 100,000 Population, UK Please include.

In Situ Breast Carcinoma (D05): 2014

Hodgkin Lymphoma (C81): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England.

All Cancers Excluding Non-Melanoma Skin Cancer (C00-97 Excl

Hodgkin Lymphoma Subtypes:

Cervical Cancer (C53): European Age-Standardised Incidence Rates per 100,000 Population, Females, Great Britain Please include the citation provided.

Lung Cancer (C33-C34): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Kidney Cancer (C64-C66,C68): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England.

Vulval Cancer (C51): European Age-Standardised Incidence Rates per 100,000 Population, by Age, Females, Great Britain Please include the citation.

Oesophageal Cancer (C15): 2011

Bone Sarcoma (C40-C41): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Malignant Melanoma (C43): 2014

Cervical Cancer (C53): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.

Prostate Cancer (C61): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Males, UK Northern England.

Oral Cancer (C00-C06,C09-C10,C12-C14): 2014

Bowel Cancer (C18-C20): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Oesophageal Cancer (C15): 2014

Myeloma (C90): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Brain, Other CNS and Intracranial Tumours (C70-C72, C75. 1-C75

Oral Cancer (C00-C06,C09-C10,C12-C14): 2011

Bladder Cancer (C67): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Oesophageal Cancer (C15): 2010

Bowel Cancer (C18-C20): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England.

Anal Cancer (C21): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Pancreatic Cancer (C25): 2014

Leukaemia (C91-C95): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK Northern England Wales.

Eye Cancer (C69): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales Scotland.

Pancreatic Cancer (C25): 31st December 2006

Uterine Cancer (C54-C55): 2011 Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, Females, UK Northern.

Leukaemia (C91-C95): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Luekaemia (C91-C95): European Age-Standardised Incidence Rates per 100,000 Population, by Age, Persons, Great Britain Please include the citation.

Gallbladder Cancer (C23): 2014

Cancer of Unknown Primary (C77-C80): 2014

The 20 Most Common Causes of Cancer Death in 2012

Breast Cancer (C50): 2014 Numbers of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Scotland.

Stomach Cancer (C16): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Thyroid Cancer (C73): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Laryngeal Cancer (C32): 2014 Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK Northern England Wales.

Presentation transcript:

Bowel Cancer Subtypes (C18-C20): 2011 Numbers of New Cases and European Age-Standardised Incidence (AS) Rates per 100,000, UK Male Female Persons Cases 14,279 13,076 27,355 Crude Rate 45.9 40.7 43.3 Colon (C18) AS Rate 35.2 26.2 30.3 AS Rate - 95% LCL 34.7 25.8 29.9 AS Rate - 95% UCL 35.8 26.7 30.7 Cases 8,892 5,334 14,226 Crude Rate 28.6 16.6 22.5 Rectum and Rectosigmoid AS Rate 22.8 11.4 16.7 Junction (C19-C20) AS Rate - 95% LCL 22.3 11.1 16.4 AS Rate - 95% UCL 23.2 11.7 17.0 95% LCL and 95% UCL are the 95% lower and upper confidence limits around the AS Rate Please include the citation provided in our Frequently Asked Questions when reproducing this chart: http://info.cancerresearchuk.org/cancerstats/faqs/#How Prepared by Cancer Research UK Original data sources: 1. Office for National Statistics. Cancer Statistics: Registrations Series MB1. http://www.ons.gov.uk/ons/search/index.html?newquery=series+mb1 2. Welsh Cancer Intelligence and Surveillance Unit. http://www.wcisu.wales.nhs.uk 3. Information Services Division Scotland. Cancer Information Programme. www.isdscotland.org/cancer 4. N. Ireland Cancer Registry. www.qub.ac.uk/nicr.